12:00 AM
 | 
Mar 05, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Factor VIIa-albumin fusion protein regulatory update

FDA granted Orphan Drug designation for CSL's rVIIa-FP to treat and prevent bleeding episodes in patients with...

Read the full 61 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >